EGFR and neoplasm: Correspondingly, direct injection of a liposome-encapsulated miR-7 plasmid into established EGFR-TKI sensitive and resistant tumors bearing the T790M EGFR mutant resulted in significant tumor regression in conjunction with repression of EGFR, RAF-1 and IRS-1 expression.142